LDS/Medical Tests/Inducible Costimulator (ICOS) Gene mutation analysis

Inducible Costimulator (ICOS) Gene mutation analysis

The inducible costimulator (ICOS) gene, located on chromosome 2q33.2, encodes a member of the CD28/CTLA-4 family of costimulatory receptors. ICOS is expressed on activated T-cells, particularly follicular helper T-cells (Tfh), and plays a key role in cell–cell signaling, immune response regulation, and T-cell proliferation and survival. Upon activation, ICOS interacts with its ligand (ICOSL) on antigen-presenting cells, generating a costimulatory signal that induces T-cell proliferation, cytokine production, and immune regulation.

Mutations in ICOS impair T-cell function, resulting in immune dysregulation syndromes, including immunodeficiency disorders and autoimmunity. In diagnostic practice, ICOS serves as a sensitive immunohistochemical marker for T-cell lymphomas of follicular helper origin, such as angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphoma with Tfh phenotype (PTCL-TFH).

Additionally, aberrant ICOS expression has been observed in multiple cancers. Overexpression has been associated with poor prognosis in uveal melanoma and lower-grade glioma, but with favorable outcomes in cutaneous melanoma, thymoma, uterine corpus endometrial carcinoma, and head and neck squamous cell carcinoma. This prognostic heterogeneity likely reflects differences in ICOS-mediated signaling and the role of ICOS in tumor–immune microenvironment interactions.

  • Aids in the diagnosis of common variable immunodeficiency (CVID)
  • Helpful for the investigation and prognostication of different cancers

Positive: Mutation or pathogenic variant in the ICOS gene detected. Supports diagnosis of CVID or may indicate altered immune regulation relevant to lymphoma or other cancers.

Negative: No mutation detected. Does not completely exclude CVID or other immune dysregulation syndromes; clinical correlation is required.

Negative (No mutations or pathogenic variants detected)

Allele Specific Primer Extension (ARMS) by Real-time Polymerase chain reaction (PCR), Next generation sequencing (NGS), Conventional Sequencing.

Whole blood, EDTA.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
BAFF-R, CBC, B-cell phenotyping, IgG subclasses, HIV ELISA.
3 to 7 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login